Celyad Oncology sells 28.8% shares to Fortress Group for $32.5mn
BRUSSELS, BELGIUM: Celyad Oncology SA has entered into a subscription agreement with an affiliate of Fortress Investment Group for the private placement of 6.5 million...
Celyad Oncology signs $40 million equity purchase agreement with Lincoln Park Capital
BRUSSELS: Celyad Oncology SA has entered into a committed equity purchase agreement for up to $40 million with Lincoln Park Capital Fund LLC, a Chicago-based...